Pfizer paying $35M to settle allegations of illegal marketing of kidney-transplant drug

August 6, 2014 8:30 PM

10 0

WASHINGTON — Pfizer will pay $35 million to resolve allegations by 42 states that its subsidiary, Wyeth Pharmaceuticals, illegally marketed an organ transplant drug for unapproved uses.

The states' attorneys general said Wednesday that Wyeth, which Pfizer bought in 2009, trained sales representatives to encourage doctors to prescribe Rapamune for uses other than preventing rejection of transplanted kidneys.

Also read: Pfizer Alleges J&J Thwarted Competition to Remicade, in Legal Test of Biotech-Drug Copies

Read more

To category page

Loading...